Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 1
1944 3
1945 1
1947 4
1948 4
1949 1
1950 1
1951 1
1964 2
1965 6
1966 4
1967 3
1968 3
1969 2
1971 2
1972 1
1973 1
1976 3
1977 2
1979 3
1980 3
1981 1
1982 8
1983 5
1984 4
1985 5
1986 5
1987 5
1988 9
1989 6
1990 7
1991 9
1992 12
1993 11
1994 18
1995 16
1996 22
1997 25
1998 30
1999 38
2000 45
2001 49
2002 84
2003 110
2004 132
2005 157
2006 172
2007 203
2008 253
2009 272
2010 324
2011 441
2012 427
2013 412
2014 478
2015 513
2016 476
2017 553
2018 556
2019 562
2020 589
2021 614
2022 560
2023 568
2024 560
2025 591
2026 174

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,089 results

Results by year

Filters applied: . Clear all
Page 1
Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers.
Hyeon DY, Nam D, Shin HJ, Jeong J, Jung E, Cho SY, Shin DH, Ku JL, Baek HJ, Yoo CW, Hong EK, Lim MC, Lee SJ, Bae YK, Kim JK, Bae J, Choi W, Kim SJ, Back S, Kang C, Madar IH, Kim H, Kim S, Kim DK, Kang J, Park GW, Park KS, Shin Y, Kim SS, Jung K, Hwang D, Lee SW, Kim JY. Hyeon DY, et al. Among authors: lee sw. Mol Cancer. 2025 Mar 14;24(1):77. doi: 10.1186/s12943-025-02256-3. Mol Cancer. 2025. PMID: 40087745 Free PMC article.
Global, regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: A Global Burden of Disease study 2021.
GBD 2021 Headache Collaborators. Electronic address: yonkkang@gmail.com; Wijeratne T, Oh J, Kim S, Yim Y, Kim MS, Shin JI, Oh YS, Jung R, Kim YS, Smith L, Aalruz H, Abd-Rabu R, Abdulah DM, Aboagye RG, Abolmaali M, Abtahi D, Abualhasan A, Adedoyin RA, Adnani QES, Afrashteh F, Aggarwal N, Ahmad D, Ahmadi A, Ahmadi NS, Ahmadzade AM, Ahmed SA, Al Awaidy S, Alabbad S, Alajlani MM, Al-Ajlouni Y, Ali MU, Ali SS, Ali W, Almazan JU, Alshahrani NZ, Altaf A, Al-Wardat M, Alzoubi KH, Amiri S, Amu H, Amusa GA, Anderson DB, Anwar S, Areda D, Asghari-Jafarabadi M, Ashina S, Ashraf J, Ashraf T, Azargoonjahromi A, Bahurupi Y, Baig AA, Bandyopadhyay S, Bardhan M, Barqawi HJ, Bashiri A, Bastan MM, Bemanalizadeh M, Bensenor IM, Berhie AYY, Bhagavathula AS, Bhaskar S, Bhat V, Bhatti GK, Bhatti JS, Bilgin C, Biswas A, Bizzozero-Peroni B, Bustanji Y, Cámera LA, Caronna E, Carvalho AF, Chakraborty S, Ching PR, Christodoulou N, Chu DT, Chu H, Cruz-Martins N, Dadras O, Dai X, D'Amico E, Darwish AH, Deekonda S, Devanbu VGC, Dharmaratne SD, Dima A, Dinkayehu TE, Do H, Doku PN, Doshi OP, E'mar AR, Eissazade N, Eltaha C, Fahim A, Fares J, Farjoud Kouhanjani M, Faro A, Fazeli P, Fereshtehnejad SM, Ferrara P, Fe… See abstract for full author list ➔ GBD 2021 Headache Collaborators. Electronic address: yonkkang@gmail.com, et al. Among authors: lee sw. Cell Rep Med. 2025 Oct 21;6(10):102348. doi: 10.1016/j.xcrm.2025.102348. Epub 2025 Sep 18. Cell Rep Med. 2025. PMID: 40972580 Free PMC article.
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery.
Kang DY, Lee SH, Lee SW, Lee CH, Kim C, Jang JY, Mehta N, Oh JH, Cho YR, Yoon KH, Ahn SG, Lee JH, Cho DK, Kim Y, Kim J, Cho GH, Lee KS, Park H, Vural M, Lim YH, Park KH, Lee BK, Lee JY, Park HW, Yoon YH, Lee JH, Lee SY, Park KW, Kang J, Kim HK, Kang SH, Park JH, Choi IC, Yu CS, Yun SC, Park DW, Hong MK, Park SJ, Kim JS, Ahn JM; ASSURE DES Investigators. Kang DY, et al. Among authors: lee sw. J Am Coll Cardiol. 2024 Dec 10;84(24):2380-2389. doi: 10.1016/j.jacc.2024.08.024. Epub 2024 Aug 31. J Am Coll Cardiol. 2024. PMID: 39217573 Free article. Clinical Trial.
Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic Ulcer.
Hong S, Ju JH, Lee SH, Hong SJ, Kim SH, Ahn GY, Jung JH, Hur JW, Ha YJ, Park JK, Kim HS, Lee SW, Park YB, Lim MJ, Kim YS, Song JS, Choi CB, Kim SH, Choi IA, Choi KD, Lee TH, Cho YS, Lee YC, Kwon KS, Lee H, Park M, Heo J, Baek S, Lee CK. Hong S, et al. Among authors: lee sw. Gut Liver. 2025 Sep 15;19(5):685-695. doi: 10.5009/gnl250019. Epub 2025 Jun 26. Gut Liver. 2025. PMID: 40567214 Free PMC article. Clinical Trial.
Reweighting simulated events using machine-learning techniques in the CMS experiment.
Hayrapetyan A, Tumasyan A, Adam W, Andrejkovic JW, Benato L, Bergauer T, Chatterjee S, Damanakis K, Dragicevic M, Hussain PS, Jeitler M, Krammer N, Li A, Liko D, Mikulec I, Schieck J, Schöfbeck R, Schwarz D, Sonawane M, Waltenberger W, Wulz CE, Janssen T, Van Laer T, Van Mechelen P, Breugelmans N, D'Hondt J, Dansana S, De Moor A, Delcourt M, Heyen F, Lowette S, Makarenko I, Müller D, Tavernier S, Tytgat M, Van Onsem GP, Van Putte S, Vannerom D, Bilin B, Clerbaux B, Das AK, De Bruyn I, De Lentdecker G, Evard H, Favart L, Gianneios P, Jaramillo J, Khalilzadeh A, Khan FA, Lee K, Malara A, Paredes S, Shahzad MA, Thomas L, Vanden Bemden M, Vander Velde C, Vanlaer P, De Coen M, Dobur D, Gokbulut G, Hong Y, Knolle J, Lambrecht L, Marckx D, Mota Amarilo K, Skovpen K, Van Den Bossche N, van der Linden J, Wezenbeek L, Benecke A, Bethani A, Bruno G, Caputo C, De Favereau De Jeneret J, Delaere C, Donertas IS, Giammanco A, Guzel AO, Jain S, Lemaitre V, Lidrych J, Mastrapasqua P, Tran TT, Turkcapar S, Alves GA, Coelho E, Correia Silva G, Hensel C, Menezes De Oliveira T, Mora Herrera C, Rebello Teles P, Soeiro M, Tonelli Manganote EJ, Vilela Pereira A, Aldá Júnior WL, Barroso Ferreira Filho M, B… See abstract for full author list ➔ Hayrapetyan A, et al. Among authors: lee sw. Eur Phys J C Part Fields. 2025;85(5):495. doi: 10.1140/epjc/s10052-025-14097-x. Epub 2025 May 6. Eur Phys J C Part Fields. 2025. PMID: 40342237 Free PMC article.
Hepatocellular Carcinoma Surveillance and Survival in a Contemporary Asia-Pacific Cohort.
Lim RY, Koh B, Ng CH, Kulkarni AV, Liu K, Wijarnpreecha K, Kim BK, Muthiah MD, Lee SW, Zheng MH, Kawaguchi T, Takahashi H, Huang DQ; Liver Cancer Research Network. Lim RY, et al. Among authors: lee sw. JAMA Netw Open. 2025 Jul 1;8(7):e2520294. doi: 10.1001/jamanetworkopen.2025.20294. JAMA Netw Open. 2025. PMID: 40643909 Free PMC article.
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab.
Nam H, Kim DY, Kim DY, Kim JH, Kim CW, Lee J, Yang K, Han JW, Sung PS, Yoon SK, Cho HS, Yang H, Bae SH, Lee SK, Kwon JH, Nam SW, Lee A, Song DS, Chang UI, Kim SH, Song MJ, Lee HL, Kim HY, Lee SW, Jang JW. Nam H, et al. Among authors: lee sw. Hepatology. 2025 Jun 30. doi: 10.1097/HEP.0000000000001444. Online ahead of print. Hepatology. 2025. PMID: 40587822
9,089 results